Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
strontium ranelate + calcium + vitamin D
- Development stage
- Unknown
- Lead developer
- Servier
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
A combination therapy consisting of strontium ranelate, calcium, and vitamin D used for the treatment of osteoporosis. This combination aims to strengthen bones and reduce fracture risk in patients with osteoporosis, particularly postmenopausal women. Strontium ranelate works through a dual mechanism of action, simultaneously increasing bone formation and reducing bone resorption. Calcium is essential for bone structure, while vitamin D facilitates calcium absorption.
02
Targets
CaSR (Extracellular calcium-sensing receptor)
Beyond the preview
Go deeper on strontium ranelate + calcium + vitamin D.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on strontium ranelate + calcium + vitamin D.